Journey Medical (DERM) Net Equity Issued and Repurchased (2021 - 2025)
Journey Medical's (DERM) quarterly Net Equity Issued and Repurchased came in at $5.4 million in Q4 2025, down 12.57% YoY from $6.2 million in Q4 2024, and down 21.35% on a QoQ basis from $6.9 million in Q3 2025.
Journey Medical (DERM) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Journey Medical (DERM) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $5.4 million in Q4 2025.
- Quarterly Net Equity Issued and Repurchased fell 12.57% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.4 million (up 107.68% YoY) and the FY2025 annual result came in at $16.4 million, up 107.68% from the prior year.
- Net Equity Issued and Repurchased declined to $5.4 million in Q4 2025, from $6.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $12.5 million in Q1 2021 to a low of $194000.0 in Q3 2024.
- A 3-year average of $4.8 million and a median of $4.6 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 3452.06% in 2025, down 12.57% in 2025.
- Tracing DERM's Net Equity Issued and Repurchased over 3 years: stood at $4.6 million in 2021, then jumped by 33.74% to $6.2 million in 2024, then dropped by 12.57% to $5.4 million in 2025.
- The last three Net Equity Issued and Repurchased figures came in at $5.4 million (Q4 2025), $6.9 million (Q3 2025), and $4.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.42 Mn |
| Dec 31, 2025 | 5.42 Mn |
| Sep 30, 2025 | 6.89 Mn |
| Sep 30, 2025 | 6.89 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Mar 31, 2025 | 4.05 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 194,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Sep 30, 2021 | 4.64 Mn |
| Sep 30, 2021 | 4.64 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | 1.80 Mn |
| Mar 31, 2021 | 12.54 Mn |
| Mar 31, 2021 | 12.54 Mn |